<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>lentigo maligna Archives - MoleMax Systems</title>
	<atom:link href="https://molemaxsystems.com/tag/lentigo-maligna/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Provide the best skin imaging device</description>
	<lastBuildDate>Tue, 20 Jan 2026 09:17:49 +0000</lastBuildDate>
	<language>en-AU</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://molemaxsystems.com/wp-content/uploads/2020/10/favicon.png</url>
	<title>lentigo maligna Archives - MoleMax Systems</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Extrafacial Lentigo Maligna: A Clinical And Dermoscopic Analysis According to Localization</title>
		<link>https://molemaxsystems.com/extrafacial-lentigo-maligna-a-clinical-and-dermoscopic-analysis-according-to-localization/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Thu, 28 Jul 2022 03:34:57 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[dermatology]]></category>
		<category><![CDATA[dermatology research]]></category>
		<category><![CDATA[dermoscopic]]></category>
		<category><![CDATA[lentigo maligna]]></category>
		<category><![CDATA[skin cancer]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com//?p=3242</guid>

					<description><![CDATA[<p>National Library of Medicine &#8211; published January 2022 Gabriel Salerni , Emilia Cohen-Sabban , Horacio Cabo &#160; &#160; Introduction: Whether extrafacial lentigo maligna (EFLM) differs clinically and/or dermoscopically according to location has not been analyzed...</p>
<p>The post <a href="https://molemaxsystems.com/extrafacial-lentigo-maligna-a-clinical-and-dermoscopic-analysis-according-to-localization/">Extrafacial Lentigo Maligna: A Clinical And Dermoscopic Analysis According to Localization</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">National Library of Medicine &#8211; published January 2022</p>



<p class="wp-block-paragraph"><strong>Gabriel Salerni<sup> </sup>, Emilia Cohen-Sabban<sup> </sup>, Horacio Cabo</strong></p>


<hr class="wp-block-separator" />


<p class="wp-block-paragraph">&nbsp;</p>



<p class="wp-block-paragraph">&nbsp;</p>



<p class="wp-block-paragraph"><strong>Introduction: </strong>Whether extrafacial lentigo maligna (EFLM) differs clinically and/or dermoscopically according to location has not been analyzed in depth.</p>



<p class="wp-block-paragraph"><strong>Objectives: </strong>To evaluate clinical and dermoscopic characteristics regarding different localization in a series of EFLM.</p>



<p class="wp-block-paragraph"><strong>Methods: </strong>We conducted a retrospective analysis of clinical and dermoscopic characteristics of 69 histologically proven EFLM retrieved from the database of two private institutions.</p>



<p class="wp-block-paragraph"><strong>Results</strong>: Of the 69 EFLM included in the study, 25 (36.2%) were located in posterior trunk (PT), 16 (23.2%) in anterior trunk (AT), 15 (21%) in upper extremities (UE), and 13 (18.8%) in lower extremities (LE). Mean diameter among localization were as follows: 14.3 mm in PT, 11.8 mm in AT, 14 mm in UE, and 10 mm in LE (p 0.44). The most frequent dermoscopic criteria were angulated lines and tan structureless areas (70%), followed by atypical pigment network (60%), both with similar distribution among groups. Angulated lines pattern was the most frequent global pattern, observed in 55% of cases. Tan structureless/granularity pattern and patchy peripheral pigmented islands pattern were seen in 15.6% and 11.6% cases, respectively. No statistically significant differences were observed in the distribution of global dermoscopic pattern in the different localizations. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824700/">T</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824700/" target="_blank" rel="noreferrer noopener">o read more click here</a></p>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/uncategorised-hi/">UNCATEGORISED</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/extrafacial-lentigo-maligna-a-clinical-and-dermoscopic-analysis-according-to-localization/">Extrafacial Lentigo Maligna: A Clinical And Dermoscopic Analysis According to Localization</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
